//
sign in
Profile
by @danabra.mov
Profile
by @dansshadow.bsky.social
Profile
by @jimpick.com
AviHandle
by @danabra.mov
AviHandle
by @dansshadow.bsky.social
AviHandle
by @katherine.computer
EventsList
by @katherine.computer
ProfileHeader
by @dansshadow.bsky.social
ProfileHeader
by @danabra.mov
ProfileMedia
by @danabra.mov
ProfilePlays
by @danabra.mov
ProfilePosts
by @danabra.mov
ProfilePosts
by @dansshadow.bsky.social
ProfileReplies
by @danabra.mov
Record
by @atsui.org
Skircle
by @danabra.mov
StreamPlacePlaylist
by @katherine.computer
+ new component
Profile
Loading...
Dendritic cell lovers, aiming to beat cancer
Laoui Team @ VIB-VUB









Loading...
Beautiful talk by @obenaufa.bsky.social at #THPT25 โ€” first walking us through the key conclusions of her latest Nature paper, then offering a glimpse into the next chapter of her work unravelling the mysteries of drug tolerant persistent cells. Looking forward to see where this story goes next!
Continuing the interesting talks at VIB #THPT25. Leanne Li discussed the heterogeneity and metabolic interplay in SCLC, showing that survival increases when blocking electrical activity in neuroendocrine cells. Great example of how fundamental insights can give rise to new therapeutic approaches!
6mo
After an insightful morning focused on metastasis, we open the afternoon with a mindblowing talk of Jennifer Wargo. She discussed how microbiota can influence immunotherapy responses and the impact of fibers. To say it in her words: "The issue is in the tissue and the scoop is in the poop!" #THPT25
Last day of #THPT25 โ€” and definitely not the least! Captivating talk by Celine Valot from the Curie Institute, spotlighting her research on how epigenomic changes in luminal cells contribute to the early onset of breast cancer. An inspiring highlight as we continue through the day!
Always proud to see our lab so well represented at a conference! Our PhD researchers Lize and Alicia, along with Postdoc Federica, presented their work during the poster sessions. Come meet them to get the latest updates on our research at #THPT25!
๐Ÿšจ New paper alert: We developed a patient-relevant orthotopic mouse #lungcancer model and combined SEPARATE-Seq together with targeted #spatialtranscriptomics to map the immune landscape and uncovered important specialized immune niches. Read it here ๐Ÿ‘‰ www.nature.com/articles/s41...
One week left to register for the FEBS Advanced Course on Tumour Microenvironment: From Tumour Heterogeneity to Therapy Resistance. which will be held in May 4-8, 2026, in Crete! ๐Ÿง‘โ€๐Ÿ”ฌ ๐Ÿงช ๐Ÿ”ฌ There is an excellent line up of internationally recognized speakers! tumourmicroenvironment2026.febsevents.org
Curious about MATRACs and their potential in cancer therapy? Check out this short video poster pitch from our PostDoc Federica at #THPT25 to learn how this emerging approach could make a difference! www.linkedin.com/feed/update/...
What an excellent way to kick of the #THPT25 conference! Keynote Johanna Joyce showed her latest insights in the complexity of the TME and talked about her promising results on preventing scar formation in brain cancer to reduce relapse and improve survival. @vibtrainconf.bsky.social
6mo
6mo
6mo
6mo
The Tumor Heterogeneity, Plasticity and Therapy Conference #THPT25 is almost here!โฐRegistration closes Nov 26th vibbio.tech/THPT25. Don't miss this chance to hear more from Leanne Li (The Francis Crick Institute, UK) who focuses on combining cancer biology and neuroscience @leanneli.bsky.social
1mo
3mo
6mo
6mo
Laoui Team @ VIB-VUB
6mo
Laoui Team @ VIB-VUB
Laoui Team @ VIB-VUB
Laoui Team @ VIB-VUB
Laoui Team @ VIB-VUB
Laoui Team @ VIB-VUB
Laoui Team @ VIB-VUB
Laoui Team @ VIB-VUB
Laoui Team @ VIB-VUB
Laoui Team @ VIB-VUB
4โ€“8 May 2026 โ”‚ Fodele, Greece
tumourmicroenvironment2026.febsevents.org
FEBS Advanced Lecture Course 2026 - Tumour microenvironment: From tumour heterogeneity to therapy resistance
#thpt25 #tumorimmunology #cytokinetherapy #immunoengineering #cancerimmunity #vib #postdoclife #vibconf | VIB Training & Conferences
โšก ๐—–๐—ฎ๐—ป ๐˜„๐—ฒ ๐—ต๐—ฎ๐—ฟ๐—ป๐—ฒ๐˜€๐˜€ ๐—ฎ ๐˜‚๐—ป๐—ถ๐˜ƒ๐—ฒ๐—ฟ๐˜€๐—ฎ๐—น ๐—ณ๐—ฒ๐—ฎ๐˜๐˜‚๐—ฟ๐—ฒ ๐—ผ๐—ณ ๐˜€๐—ผ๐—น๐—ถ๐—ฑ ๐˜๐˜‚๐—บ๐—ผ๐—ฟ๐˜€ ๐˜๐—ผ ๐—ฑ๐—ฒ๐—น๐—ถ๐˜ƒ๐—ฒ๐—ฟ ๐—ถ๐—บ๐—บ๐˜‚๐—ป๐—ถ๐˜๐˜†-๐—ฏ๐—ผ๐—ผ๐˜€๐˜๐—ถ๐—ป๐—ด ๐˜€๐—ถ๐—ด๐—ป๐—ฎ๐—น๐˜€ ๐—ฒ๐˜…๐—ฎ๐—ฐ๐˜๐—น๐˜† ๐˜„๐—ต๐—ฒ๐—ฟ๐—ฒ ๐˜๐—ต๐—ฒ๐˜†โ€™๐—ฟ๐—ฒ ๐—ป๐—ฒ๐—ฒ๐—ฑ๐—ฒ๐—ฑ? To answer this, we spoke with Federica Cappellesso at #THPT25, who works in the...
www.linkedin.com
This link will take you to a page thatโ€™s not on LinkedIn
lnkd.in
LinkedIn